{"Title":"FDA expands use of AstraZeneca\/Merck ovarian cancer drug","Date":1502928000000}
{"Title":"FTSE 100 ends flat as WPP sinks","Date":1503446400000}
{"Title":"AstraZeneca taps AI for drug discovery in deal with Berg","Date":1503878400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.99%","Date":1504051200000}
{"Title":"Daiichi Sankyo denies receiving takeover bid from AstraZeneca","Date":1504137600000}
{"Title":"AstraZeneca sought to buy Japan's Daiichi Sankyo last year -report","Date":1504137600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.77%","Date":1504224000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.37%","Date":1504656000000}
{"Title":"New AstraZeneca, Amgen biotech drug offers broad asthma relief","Date":1504656000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.76%","Date":1504742400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.67%","Date":1504742400000}
{"Title":"Merck's immunotherapy, chemo mix shows extended lung cancer gains","Date":1504742400000}
{"Title":"AstraZeneca rebuilds cancer drug hopes with new lung data","Date":1504915200000}
{"Title":"Insurers lead European shares higher as Hurricane Irma weakens","Date":1505088000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.28%","Date":1505088000000}
{"Title":"Sterling's slip from one-year high curbs FTSE losses","Date":1505260800000}
{"Title":"Aspen to buy remaining AstraZeneca anaesthetic rights for up to $766 million","Date":1505347200000}
{"Title":"Gates Foundation invests $40 million in UK immunotherapy company","Date":1505692800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.10%","Date":1505779200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.68%","Date":1506038400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.28%","Date":1506038400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.21%","Date":1506297600000}
{"Title":"Drugs firm AstraZeneca wants three-year Brexit transition","Date":1506902400000}
{"Title":"Tell us how Brexit will work, British companies demand","Date":1506902400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.17%","Date":1506902400000}
{"Title":"Drug industry gives up legal battle over new UK cost curbs","Date":1507161600000}
{"Title":"FTSE at two-month peak as sterling falters","Date":1507248000000}
{"Title":"Pharma and medtech industries prepare for hard Brexit","Date":1508112000000}
{"Title":"China biotech's 'coming out party' masks long road ahead","Date":1508371200000}
{"Title":"AstraZeneca among backers as Swiss cancer biotech raises $200 million","Date":1508716800000}
{"Title":"Merck tops profit estimates on Keytruda sales","Date":1509062400000}
{"Title":"AstraZeneca licenses genetic disease drug to Mereo BioPharma","Date":1509321600000}
{"Title":"AstraZeneca plans new pivotal lung cancer trial with Incyte","Date":1509408000000}
{"Title":"Pfizer Consumer Unit's Sales Fall Ahead of Divestiture Call","Date":1509408000000}
{"Title":"AstraZeneca asthma drug tralokinumab disappoints again","Date":1509494400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.04%","Date":1509580800000}
{"Title":"GSK's R&D head to leave for top UK government job - source","Date":1509667200000}
{"Title":"Former GSK boss to lead new UK accelerated drug access scheme","Date":1509667200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.35%","Date":1510012800000}
{"Title":"Short seller Kerrisdale targets Woodford-backed Prothena","Date":1510099200000}
{"Title":"GSK grabs Roche veteran and Calico scientist Barron as new R&amp;D head","Date":1510099200000}
{"Title":"AstraZeneca third-quarter sales weak as it waits for medicine to work","Date":1510185600000}
{"Title":"European shares dip slightly as more third quarter earnings announced","Date":1510185600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.25%","Date":1510531200000}
{"Title":"Banks drag FTSE to six-week low, mid-caps hit by pound","Date":1510531200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.12%","Date":1510617600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.09%","Date":1510704000000}
{"Title":"FTSE recoups early losses as cyclicals recover","Date":1511136000000}
{"Title":"Brexit gets real for drugmakers as regulator moves to Amsterdam","Date":1511222400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.21%","Date":1512000000000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.94%","Date":1512000000000}
{"Title":"Roche to seize leap-frog opportunity in lung cancer","Date":1512518400000}
{"Title":"Over 20 percent of UK companies faced shareholder revolt - pay study","Date":1513641600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.41%","Date":1514419200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.07%","Date":1514419200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.73%","Date":1514505600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.64%","Date":1514505600000}
{"Title":"New drug approvals hit 21-year high in 2017","Date":1514851200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.01%","Date":1515024000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.18%","Date":1515542400000}
{"Title":"At AstraZeneca, fewer drug projects bring big productivity jump","Date":1516320000000}
{"Title":"AstraZeneca's inhaler for lung disease shows improved function in late stage trial","Date":1516924800000}
{"Title":"UK stocks end two days of currency-driven declines","Date":1516924800000}
{"Title":"AstraZeneca is sued by Array BioPharma over cancer drug royalties","Date":1517443200000}
{"Title":"Results, risk aversion drag FTSE 100 to worst week in nine months","Date":1517529600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.62%","Date":1517529600000}
{"Title":"Deutsche Bank drags European shares towards worst weekly loss since August","Date":1517529600000}
{"Title":"AstraZeneca flags return to drug growth in 2018, China shines","Date":1517529600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.06%","Date":1517529600000}
{"Title":"AstraZeneca links with Alibaba and Tencent in China push","Date":1517529600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 1.46%","Date":1517788800000}
{"Title":"GlaxoSmithKline sees light at end of Advair tunnel","Date":1517961600000}
{"Title":"FTSE slides after BOE meeting as pound pops higher","Date":1518048000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 2.02%","Date":1518048000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.29%","Date":1518134400000}
{"Title":"Commodities help FTSE 100 outperform European stocks","Date":1518480000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.69%","Date":1518652800000}
{"Title":"Cyclicals, South Africa-exposed stocks help steady FTSE 100","Date":1518652800000}
{"Title":"U.S. FDA approves AstraZeneca's immunotherapy for lung cancer","Date":1518739200000}
{"Title":"AstraZeneca's immunotherapy drug wins key lung cancer approval","Date":1518998400000}
{"Title":"U.S. health officials reverse stance on AstraZeneca's flu vaccine","Date":1519171200000}
{"Title":"Big pharma, big data - why drugmakers want your health records","Date":1519862400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.78%","Date":1520294400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.26%","Date":1520553600000}
{"Title":"AstraZeneca sees pivotal lung cancer trial results later in 2018","Date":1520812800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.45%","Date":1520985600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.18%","Date":1521158400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.66%","Date":1521417600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 2.19%","Date":1521676800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.13%","Date":1522195200000}
{"Title":"Compugen, AstraZeneca unit in cancer drug development deal","Date":1522627200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.73%","Date":1522713600000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.03%","Date":1523836800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.24%","Date":1523923200000}
{"Title":"Industry fears disruption as EU excludes UK from drug approvals","Date":1524009600000}
{"Title":"Experts query case for GlaxoSmithKline's new 3-in-1 lung drug","Date":1524009600000}
{"Title":"AstraZeneca to raise stake in Circassia to up to 19.9 percent","Date":1524528000000}
{"Title":"Shire's mega deal fails to lift FTSE amid global gloom","Date":1524614400000}
{"Title":"FTSE 100 rises, led by Just Eat, BP, while sterling sinks","Date":1525132800000}
{"Title":"AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million","Date":1525737600000}
{"Title":"MPs call for post-Brexit pharmaceutical deal with EU","Date":1526515200000}
{"Title":"GSK bets on lift from new lung drugs ahead of Advair's last gasp","Date":1526601600000}
{"Title":"AstraZeneca insists future is bright after big Crestor sales hit","Date":1526601600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.16%","Date":1526601600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.10%","Date":1526601600000}
{"Title":"AstraZeneca potassium drug finally approved, threatening Vifor","Date":1526860800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.29%","Date":1526860800000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.38%","Date":1527033600000}
{"Title":"AstraZeneca cancer drug hits second goal by extending survival","Date":1527206400000}
{"Title":"Oil weighs on FTSE, Kingfisher shines","Date":1527206400000}
{"Title":"EU industry lobby adds to pressure on Britain over Brexit talks","Date":1527638400000}
{"Title":"AstraZeneca drug Fasenra fails to achieve main goal in COPD trial","Date":1527638400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.26%","Date":1527811200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.30%","Date":1528070400000}
{"Title":"Emirates starts London Stansted flights as rival airports near capacity","Date":1528416000000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.71%","Date":1529625600000}
{"Title":"Hitting cancer early - AstraZeneca's bid to outmanoeuvre rivals","Date":1530835200000}
{"Title":"FTSE 100 recovers, driven by defensives, as trade nerves ebb","Date":1531353600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.00%","Date":1531353600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.79%","Date":1531353600000}
{"Title":"AstraZeneca to stockpile drugs as Brexit 'safety net'","Date":1531872000000}
{"Title":"EU drug regulators step up work to prepare for 'no deal' Brexit","Date":1532044800000}
{"Title":"GSK's new R&amp;D head bets on genetics with $300 million 23andMe deal","Date":1532476800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.98%","Date":1532563200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.11%","Date":1532563200000}
{"Title":"Shell slide weighs on FTSE as earnings in focus","Date":1532563200000}
{"Title":"European shares rise as U.S.-EU trade breakthrough spurs carmakers","Date":1532563200000}
{"Title":"AstraZeneca's key lung cancer drug wins European panel thumbs-up","Date":1532649600000}
{"Title":"Sanofi has been stockpiling drugs for no-deal Brexit - WSJ","Date":1532995200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.28%","Date":1532995200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.11%","Date":1533513600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.63%","Date":1533600000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.71%","Date":1533600000000}
{"Title":"FTSE extends gains as oil stocks power ahead; housebuilders fall","Date":1533686400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.53%","Date":1533772800000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.88%","Date":1533859200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.31%","Date":1534118400000}
{"Title":"Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance","Date":1534377600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.11%","Date":1534377600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.51%","Date":1534723200000}
{"Title":"AstraZeneca switches contractor as new headquarter delayed again","Date":1534896000000}
{"Title":"French drugmakers urge Brexit negotiators to safeguard supply chain","Date":1536192000000}
{"Title":"AstraZeneca gets FDA breakthrough therapy label for asthma treatment","Date":1536278400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.10%","Date":1536710400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.19%","Date":1536796800000}
{"Title":"AstraZeneca plots China robot offensive to counter price cuts","Date":1537315200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.10%","Date":1537833600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.10%","Date":1537920000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.09%","Date":1538006400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.84%","Date":1538092800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.31%","Date":1538352000000}
{"Title":"Pfizer to replace longtime CEO Read with veteran Bourla","Date":1538352000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.90%","Date":1539302400000}
{"Title":"AstraZeneca will keep UK investment freeze if no Brexit clarity","Date":1539561600000}
{"Title":"Beset by copies, Roche gets sales boost from China","Date":1539734400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.38%","Date":1539734400000}
{"Title":"AstraZeneca digs deeper into cancer with Innate stake","Date":1540252800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.30%","Date":1540425600000}
{"Title":"AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal","Date":1540857600000}
{"Title":"Why I think it might finally be time to buy FTSE 100 dividend stock GlaxoSmithKline","Date":1540944000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.46%","Date":1541030400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.19%","Date":1541030400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.80%","Date":1541376000000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.15%","Date":1541376000000}
{"Title":"Evraz, Micro Focus lead FTSE higher in choppy trade","Date":1541376000000}
{"Title":"AstraZeneca sells older asthma, rhinitis drugs for $350 million","Date":1541462400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.29%","Date":1541462400000}
{"Title":"AstraZeneca sees years of growth as drug sales turn corner","Date":1541635200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.12%","Date":1541635200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.44%","Date":1541635200000}
{"Title":"AstraZeneca lifts FTSE as U.S. midterm rally fades","Date":1541635200000}
{"Title":"FTSE outperforms European peers as Brexit angst sinks sterling","Date":1541980800000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.04%","Date":1541980800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.65%","Date":1542326400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.73%","Date":1542672000000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.48%","Date":1542758400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.75%","Date":1542931200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.41%","Date":1543190400000}
{"Title":"Biocartis partners with AstraZeneca on lung cancer diagnostics","Date":1543449600000}
{"Title":"GSK buys U.S. cancer drugmaker Tesaro for hefty $5.1 billion","Date":1543795200000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 1.53%","Date":1543881600000}
{"Title":"AstraZeneca's Imfinzi fails to meet main goals in head and neck cancer study","Date":1544140800000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.97%","Date":1544572800000}
{"Title":"Poor China data caps turbulent week for FTSE 100 as investors rush for exits","Date":1544745600000}
{"Title":"Pharma industry returns on R&amp;D investment hit 9-year low","Date":1545177600000}
{"Title":"AstraZeneca's ovarian cancer and anaemia treatments meet goals in late-stage studies","Date":1545264000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 2.14%","Date":1545264000000}
{"Title":"UK shares at 2-year lows, FTSE 250 flirts with bear market territory","Date":1545868800000}
{"Title":"Much-awaited holiday cheer finally arrives to UK markets","Date":1545955200000}
{"Title":"FTSE 100 slightly lower in fitting farewell to dim 2018","Date":1546214400000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.88%","Date":1546473600000}
{"Title":"Trade talk rally shortlived for FTSE","Date":1546819200000}
{"Title":"AstraZeneca picks Baselga to lead oncology R&amp;D in growth plan","Date":1546819200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.32%","Date":1546819200000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 1.22%","Date":1546905600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.89%","Date":1546992000000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.39%","Date":1547164800000}
{"Title":"FTSE dips as sterling firms on report of potential Brexit delay","Date":1547164800000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.50%","Date":1547424000000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.96%","Date":1547424000000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.40%","Date":1548028800000}
{"Title":"Sweden shares lower at close of trade; OMX Stockholm 30 down 0.51%","Date":1548201600000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.65%","Date":1548288000000}
{"Title":"Italy drugmaker Zambon ready to splash out in U.S., China push","Date":1548288000000}
{"Title":"FTSE 100 ends lower for fourth session, Vodafone hits eight-and-a-half-year low","Date":1548374400000}
{"Title":"Sweden shares higher at close of trade; OMX Stockholm 30 up 0.85%","Date":1548374400000}
{"Title":"Here\u2019s a dirt cheap way of creating a second income stream through the stock market","Date":1548460800000}
{"Title":"Top 5 Things to Know in The Market on Thursday","Date":1550102400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.34%","Date":1550102400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.58%","Date":1553817600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 1.43%","Date":1558569600000}
{"Title":"FTSE 100 hits 10-month high as sterling weakens; Telford soars","Date":1562112000000}
{"Title":"UK's main index sees seventh straight day of losses, BoE comments lift midcaps","Date":1562889600000}
{"Title":"As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff","Date":1563321600000}
{"Title":"Exclusive: Woodford biotech stakes first off block in asset sale - source","Date":1563321600000}
{"Title":"GSK names HSBC's Symonds as non-exec chairman","Date":1563926400000}
{"Title":"GSK forecasts smaller hit to full-year profit after second quarter beat","Date":1563926400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.19%","Date":1564012800000}
{"Title":"AstraZeneca lifts sales outlook after second-quarter cancer drug boost","Date":1564012800000}
{"Title":"AstraZeneca guides FTSE 100 higher; buyout powers Cobham","Date":1564012800000}
{"Title":"Glencore fall hits mining stocks as FTSE steadies","Date":1565136000000}
{"Title":"AstraZeneca's Farxiga clears late-stage heart-failure study","Date":1566259200000}
{"Title":"European shares rise for third straight session","Date":1566259200000}
{"Title":"Worries over global trade, Italy lead FTSE 100 lower","Date":1566259200000}
{"Title":"AstraZeneca's Imfinzi combination fails advanced lung cancer study","Date":1566345600000}
{"Title":"Should I sell my shares if a recession is imminent?","Date":1566604800000}
{"Title":"U.S. FDA gives fast track status to AstraZeneca's diabetes drug Farxiga","Date":1566864000000}
{"Title":"London leads European markets lower as investors play waiting game","Date":1566864000000}
{"Title":"AstraZeneca lupus drug meets main goal in study","Date":1567036800000}
{"Title":"Encouraging China trade comments, weaker pound lift FTSE 100","Date":1567036800000}
{"Title":"FTSE weathers trade fears as weaker pound boosts exporters","Date":1567382400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.11%","Date":1567382400000}
{"Title":"AstraZeneca's Tagrisso gets China OK for type of lung cancer","Date":1567555200000}
{"Title":"Stocks trading ex-dividend knock FTSE 100 lower; industrials rise","Date":1567641600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.69%","Date":1567987200000}
{"Title":"JD Sports leads FTSE 100 higher, rate cut hopes support","Date":1568073600000}
{"Title":"Brexit optimism breathes life into UK-focussed stocks","Date":1568332800000}
{"Title":"With a backup to the backup, insulin makers say they're primed for Brexit","Date":1568678400000}
{"Title":"London's FTSE 100 ends on a flat note, Sirius Minerals plunges","Date":1568678400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.64%","Date":1568851200000}
{"Title":"Banks lead FTSE 100's descent; Thomas Cook collapse buoys rivals","Date":1569196800000}
{"Title":"AstraZeneca strengthens Lynparza push with prostate cancer data","Date":1569801600000}
{"Title":"Weak U.S., euro zone data push European shares lower","Date":1569888000000}
{"Title":"UK stocks retreat as weak U.S. data adds to global growth fears","Date":1569888000000}
{"Title":"Factbox - How are businesses preparing for a 'no-deal Brexit'?","Date":1571097600000}
{"Title":"NewsBreak: Astrazeneca's Diabetes  Drug Farxiga Gets U.S. Approval","Date":1571616000000}
{"Title":"U.S. FDA approves AstraZeneca diabetes drug for treating heart failure risk","Date":1571616000000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.05%","Date":1571875200000}
{"Title":"AstraZeneca raises sales forecast after surge in cancer drugs","Date":1571875200000}
{"Title":"FTSE 100 on track for fourth session of gains","Date":1571875200000}
{"Title":"StockBeat: DAX Hits 17-Month High on Hope That Germany Has Hit Bottom","Date":1571875200000}
{"Title":"Premarket London: AstraZeneca Raises Guidance, PPI Drives RBS to Loss","Date":1571875200000}
{"Title":"The elephant in the room with AstraZeneca\u2019s latest update","Date":1572220800000}
{"Title":"What next for the AstraZeneca share price?","Date":1572307200000}
{"Title":"AstraZeneca sells European rights for schizophrenia drug to Cheplapharm","Date":1572393600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.39%","Date":1572393600000}
{"Title":"Britain's AstraZeneca launches $1 billion China investment fund with CICC","Date":1572912000000}
{"Title":"Premarket London: BA Parent Cuts Growth Estimates; AstraZeneca Success","Date":1573171200000}
{"Title":"Rising HK tensions, trade angst knock FTSE; domestic shares rally","Date":1573430400000}
{"Title":"Premarket London: Talk Talk Swings to 1H Profit; 888 Defiant","Date":1573776000000}
{"Title":"AstraZeneca shares rise on early U.S. approval for leukaemia drug","Date":1574380800000}
{"Title":"FTSE enjoys best day since July; mid-caps gain for fourth week","Date":1574380800000}
{"Title":"FTSE slips on ex-div trading, U.S.-China trade doubts","Date":1574899200000}
{"Title":"AstraZeneca's Imfinzi gets FDA priority review for small cell lung cancer","Date":1574985600000}
{"Title":"Premarket London: Boohoo Reports Record Black Friday; Ferguson Solid","Date":1575331200000}
{"Title":"FTSE falls nearly 2% as Trump puts off China trade deal hopes","Date":1575331200000}
{"Title":"FTSE gains on new Sino-U.S. trade hopes; mid-caps shine","Date":1575417600000}
{"Title":"AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment","Date":1575504000000}
{"Title":"Premarket London: DS Smith Posts Strong H1; IG Revenue Flat","Date":1575504000000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.48%","Date":1576713600000}
{"Title":"Premarket London: Shell Raises Oil Output, Sees Charges Forecast","Date":1576800000000}
{"Title":"AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer","Date":1577664000000}
{"Title":"Profit-taking puts brakes on UK stock rally","Date":1577664000000}
{"Title":"Profit-taking, firm pound hit FTSE 100 at decade-end","Date":1577750400000}
{"Title":"Premarket London: William Hill Beats Profit Expectations","Date":1578873600000}
{"Title":"Defensive stocks buoy FTSE 100 before U.S.-China trade deal","Date":1579046400000}
{"Title":"Drugmakers slash prices to be eligible for China's bulk-buy program","Date":1579305600000}
{"Title":"JPMorgan to buy Paris building to bring euro teams from London","Date":1579392000000}
{"Title":"Japan, U.S. lead survey's corporate climate change action 'A List'","Date":1579478400000}
{"Title":"Roche wins approval for cancer drug Kadcyla in fast-growing China market","Date":1579651200000}
{"Title":"AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys","Date":1580083200000}
{"Title":"FTSE 100 ends winning streak as pound rises, virus fears persist","Date":1581552000000}
{"Title":"Stocks - Europe Heads Lower; RBS, Renault, AstraZeneca Weigh","Date":1581638400000}
{"Title":"Top 5 Things to Know in the Market on Friday, February 14th","Date":1581638400000}
{"Title":"AstraZeneca's CEO reaffirms 2021 targets","Date":1581638400000}
{"Title":"FTSE 100 ends week lower after week AstraZeneca, RBS results","Date":1581638400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.58%","Date":1581638400000}
{"Title":"AstraZeneca 2020 forecasts hit by coronavirus, shares dive","Date":1581638400000}
{"Title":"Stocks - Europe Pushes Higher on Virus Hopes, Chinese Data","Date":1586822400000}
{"Title":"AstraZeneca to test impact of cancer drug Calquence on coronavirus patients","Date":1586822400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.86%","Date":1586822400000}
{"Title":"FTSE 100 ekes out gains amid oil plunge, earnings worries","Date":1587340800000}
{"Title":"AstraZeneca tests diabetes drug as possible COVID-19 treatment","Date":1587600000000}
{"Title":"AstraZeneca sticks to 2020 outlook, boosted by drug stockpiling","Date":1588118400000}
{"Title":"GSK surpasses profit expectations on pain medication stockpiling","Date":1588118400000}
{"Title":"Hopes for coronavirus treatment, surging bank shares lift FTSE 100","Date":1588118400000}
{"Title":"Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020","Date":1588204800000}
{"Title":"AstraZeneca to make Oxford University's potential COVID-19 vaccine","Date":1588204800000}
{"Title":"AstraZeneca diabetes drug gets U.S. nod to treat heart failure","Date":1588723200000}
{"Title":"Stocks - Europe Edges Lower; FTSE 100 Outperforms","Date":1588723200000}
{"Title":"FTSE 100 closes flat as virus woes offset healthcare boost","Date":1588723200000}
{"Title":"Keenly-watched COVID-19 vaccine 'won't be expensive', developer says","Date":1589500800000}
{"Title":"Here are my top 3 investing ideas of the decade for navigating the FTSE 100 stock index","Date":1589760000000}
{"Title":"AstraZeneca in talks with other governments to replicate UK vaccine deal","Date":1589760000000}
{"Title":"Top 5 Things to Know in the Market on Thursday, May 21st","Date":1590019200000}
{"Title":"Take Five: Coronavirus vaccine race is on","Date":1590105600000}
{"Title":"How one Indian company could be world's door to a COVID-19 vaccine","Date":1590105600000}
{"Title":"Project leader: Oxford's COVID-19 vaccine trial has 50% chance of success - Telegraph","Date":1590192000000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.23%","Date":1590451200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.34%","Date":1590537600000}
{"Title":"FTSE 100 up as AstraZeneca, GSK climb on vaccine hopes","Date":1590624000000}
{"Title":"UK Stocks-Factors to watch on May 28","Date":1590624000000}
{"Title":"AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity","Date":1590624000000}
{"Title":"UK Stocks-Factors to watch on May 29","Date":1590710400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on May 29","Date":1590710400000}
{"Title":"Oxford Biomedica hires French pharma veteran after signing vaccine deal","Date":1590969600000}
{"Title":"London stocks jump as retailers set to reopen from shutdown","Date":1590969600000}
{"Title":"AstraZeneca scores twin drug approvals alongside vaccine progress","Date":1590969600000}
{"Title":"Brazil to start testing Oxford vaccine against the coronavirus this month","Date":1591142400000}
{"Title":"EU to use $2.7 billion fund to buy promising COVID-19 vaccines","Date":1591228800000}
{"Title":"AstraZeneca aims at two billion doses with new COVID vaccine deals","Date":1591228800000}
{"Title":"UK stocks end lower as risk rally pauses for breath","Date":1591228800000}
{"Title":"AstraZeneca targets 2 billion doses, poor countries with COVID vaccine deals","Date":1591228800000}
{"Title":"UK Stocks-Factors to watch on June 5","Date":1591315200000}
{"Title":"AstraZeneca contacted Gilead over potential megamerger - Bloomberg News","Date":1591488000000}
{"Title":"AstraZeneca, Gilead merger doubted by Wall Street analysts","Date":1591574400000}
{"Title":"UK stocks end lower on concerns over corporate debt; AstraZeneca weighs","Date":1591574400000}
{"Title":"Stocks - Europe Slips, Consolidating After Gloomy German Data","Date":1591574400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 8","Date":1591574400000}
{"Title":"UK Stocks-Factors to watch on June 8","Date":1591574400000}
{"Title":"Oxford Biomedica eyes UK supply boost of AstraZeneca's COVID-19 vaccine","Date":1591574400000}
{"Title":"UK Stocks-Factors to watch on June 9","Date":1591660800000}
{"Title":"AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment","Date":1591660800000}
{"Title":"UK Stocks-Factors to watch on June 10","Date":1591747200000}
{"Title":"AstraZeneca agrees to supply Europe with 400 mln doses of COVID-19 vaccine","Date":1592092800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 15","Date":1592179200000}
{"Title":"Singapore scientists to start human trials of COVID-19 vaccine in August","Date":1592265600000}
{"Title":"AstraZeneca COVID-19 vaccine likely to protect for a year - CEO","Date":1592265600000}
{"Title":"Cobra Biologics signs AstraZeneca deal to supply COVID-19 vaccine","Date":1592265600000}
{"Title":"France gives its drugs industry a shot in the arm to tackle pandemic","Date":1592265600000}
{"Title":"Exclusive: EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal - sources","Date":1592438400000}
{"Title":"Pig trial of AstraZeneca's COVID-19 vaccine shows promise with two shots","Date":1592870400000}
{"Title":"Prince William visits Oxford COVID-19 vaccine developers","Date":1592956800000}
{"Title":"AstraZeneca taps Scottish firm for tenth COVID-19 vaccine supply deal","Date":1592956800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 25","Date":1593043200000}
{"Title":"Vaccine makers face biggest medical manufacturing challenge in history","Date":1593043200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 26","Date":1593129600000}
{"Title":"Daiichi Sankyo in talks with AstraZeneca on virus vaccine supply in Japan","Date":1593129600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 29","Date":1593388800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on June 30","Date":1593475200000}
{"Title":"Britain nears $625 million Sanofi\/GSK COVID-19 vaccine deal - report","Date":1593907200000}
{"Title":"Emergent signs 5-yr deal backing J&J COVID-19 vaccine","Date":1593993600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 8","Date":1594166400000}
{"Title":"Exclusive: EU secures potential COVID-19 drugs from Roche, Germany's Merck - source","Date":1594166400000}
{"Title":"Vaccine alliance says 75 countries keen to join 'COVAX' access facility","Date":1594771200000}
{"Title":"Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - Lancet","Date":1594771200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.61%","Date":1594944000000}
{"Title":"Stocks - Europe Lower Amid Doubts Over Summit; Philips Gains","Date":1595203200000}
{"Title":"Britain secures 90 million possible COVID-19 vaccine doses from Pfizer\/BioNTech, Valneva","Date":1595203200000}
{"Title":"StockBeat: AstraZeneca, Philips, Synairgen Put Virus Fight Center Stage","Date":1595203200000}
{"Title":"Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional data","Date":1595203200000}
{"Title":"FTSE 100 falls on energy losses; AstraZeneca supported by vaccine hopes","Date":1595203200000}
{"Title":"Equity markets rebound on EU fund optimism; gold edges higher","Date":1595203200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 20","Date":1595203200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.11%","Date":1595289600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 21","Date":1595289600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 22","Date":1595376000000}
{"Title":"U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine","Date":1595376000000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 24","Date":1595548800000}
{"Title":"AstraZeneca's lung disease treatment gets FDA nod","Date":1595548800000}
{"Title":"Moderna gets further $472 million U.S. award for coronavirus vaccine development","Date":1595721600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 27","Date":1595808000000}
{"Title":"AstraZeneca bets up to $6 billion on new Daiichi cancer drug","Date":1595808000000}
{"Title":"Emergent signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine","Date":1595808000000}
{"Title":"Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sources","Date":1595808000000}
{"Title":"U.S. drugmaker earnings heat up this week with spotlight on vaccine news","Date":1595808000000}
{"Title":"Moderna vaccine protects against COVID-19 in monkey study","Date":1595894400000}
{"Title":"Moderna, Pfizer start decisive COVID-19 vaccine trials, eye year-end launches","Date":1595894400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 28","Date":1595894400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on July 30","Date":1596067200000}
{"Title":"'Biggest obstacle': Where can CanSino test its vaccine abroad?","Date":1596067200000}
{"Title":"'So far, so good' on leading COVID vaccine, says AstraZeneca","Date":1596067200000}
{"Title":"The AstraZeneca share price is reassuringly expensive. I\u2019d buy it in a Stocks and Shares ISA","Date":1596067200000}
{"Title":"AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries","Date":1596067200000}
{"Title":"Lloyds, Stan Chart weigh on FTSE 100 amid global stocks rout; AstraZeneca gains","Date":1596067200000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 2.35%","Date":1596067200000}
{"Title":"Day Ahead: 3 Things to Watch for July 31","Date":1596067200000}
{"Title":"Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan","Date":1596153600000}
{"Title":"India's Wockhardt strikes deal to supply COVID-19 vaccines to UK","Date":1596412800000}
{"Title":"Japan to agree supply deal soon for AstraZeneca's coronavirus vaccine - Kyodo","Date":1596758400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Aug. 7","Date":1596758400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Aug. 10","Date":1597017600000}
{"Title":"AstraZeneca set to start making 400 million COVID-19 vaccines for Latam early in 2021","Date":1597276800000}
{"Title":"Should you be investing money in pharma stocks?","Date":1597276800000}
{"Title":"Ex-dividend trading trips FTSE 100; National Express tumbles","Date":1597276800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Aug. 13","Date":1597276800000}
{"Title":"Argentine firm behind AstraZeneca COVID vaccine Latam production sees April\/May launch","Date":1597363200000}
{"Title":"Australian COVID-19 infections set to hit one-month low","Date":1597708800000}
{"Title":"Australia locks in coronavirus vaccine deal as new cases ease","Date":1597795200000}
{"Title":"Exclusive: Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine","Date":1597968000000}
{"Title":"Stronger pound weighs on exporter-heavy FTSE 100, midcaps shine","Date":1597968000000}
{"Title":"FTSE 100 tracks Asia gains on virus treatment hopes; AstraZeneca jumps","Date":1598227200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Aug. 25","Date":1598313600000}
{"Title":"FTSE 100 gains on U.S.-China trade optimism","Date":1598313600000}
{"Title":"AstraZeneca starts trial of COVID-19 antibody treatment","Date":1598313600000}
{"Title":"EU signs contract with AstraZeneca on supply of potential COVID-19 vaccine","Date":1598486400000}
{"Title":"EU pays 336 million euros to secure AstraZeneca's potential COVID-19 vaccine","Date":1598486400000}
{"Title":"AstraZeneca's COVID-19 vaccine candidate begins late-stage U.S. study","Date":1598832000000}
{"Title":"FTSE 100 falls to 15-week low after best August since 2014","Date":1598918400000}
{"Title":"Factbox: AstraZeneca's potential coronavirus vaccine","Date":1598918400000}
{"Title":"Thanks for the COVID vaccine, but can you say that in Estonian?","Date":1598918400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept 1","Date":1598918400000}
{"Title":"AstraZeneca signs deal with Albany Molecular to produce COVID-19 vaccine candidate","Date":1599091200000}
{"Title":"Astrazeneca to begin Phase 1\/2 clinical trials of coronavirus vaccine in Japan","Date":1599177600000}
{"Title":"COVID-19 vaccine developers prepare joint safety pledge - WSJ","Date":1599264000000}
{"Title":"Sanofi France chief: future COVID-19 vaccine seen below 10 euros","Date":1599264000000}
{"Title":"Sanofi France chief sees coronavirus vaccine priced below 10 euros","Date":1599350400000}
{"Title":"Australia's CSL to manufacture two COVID-19 vaccines, shares up","Date":1599436800000}
{"Title":"Australia expects to receive AstraZeneca's COVID-19 vaccine within months","Date":1599436800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept 8","Date":1599523200000}
{"Title":"U.S., European COVID vaccine developers make pledge to uphold testing rigour","Date":1599523200000}
{"Title":"Equities rebound after three-session Nasdaq sell-off","Date":1599609600000}
{"Title":"FTSE 100 helped by weak pound; New COVID-19 restrictions hit consumer stocks","Date":1599609600000}
{"Title":"UK science adviser: other vaccine trials also likely to be paused","Date":1599609600000}
{"Title":"Top 5 Things to Know in the Market on Wednesday, September 10th","Date":1599609600000}
{"Title":"European Stocks Seen Lower; U.S. Tech Rout Weighs","Date":1599609600000}
{"Title":"Pause in AstraZeneca vaccine trial not necessarily a setback, says health minister","Date":1599609600000}
{"Title":"European shares inch higher; AstraZeneca tumbles on halting vaccine trials","Date":1599609600000}
{"Title":"UK Stocks-Factors to watch on Sept 9","Date":1599609600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept 10","Date":1599696000000}
{"Title":"AstraZeneca expects COVID vaccine result by year-end if trials resume","Date":1599696000000}
{"Title":"U.S. weekly jobless claims stuck at higher levels","Date":1599696000000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept. 11","Date":1599782400000}
{"Title":"AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness","Date":1599955200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept. 14","Date":1600041600000}
{"Title":"AstraZeneca shares gain as coronavirus vaccine trials resume","Date":1600041600000}
{"Title":"AstraZeneca's UK COVID-19 vaccine trials restarted, EU medical register shows","Date":1600041600000}
{"Title":"Regeneron's antibody drug added to UK Recovery trial of COVID treatments","Date":1600041600000}
{"Title":"FTSE 100 closes lower on weak oil majors; Midcaps boosted by G4S","Date":1600041600000}
{"Title":"Dow Rallies on Positive Vaccine News; Tech Jumps","Date":1600041600000}
{"Title":"Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources","Date":1600041600000}
{"Title":"Germany grants BioNTech, CureVac $745 million to speed up COVID-19 vaccine work","Date":1600128000000}
{"Title":"Asian stocks gain as upbeat China data lifts mood","Date":1600128000000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept. 15","Date":1600128000000}
{"Title":"In coronavirus vaccine race, China inoculates thousands before trials are completed","Date":1600214400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept 16","Date":1600214400000}
{"Title":"AstraZeneca's trial illnesses may not be due to COVID-19 shot - Oxford University","Date":1600214400000}
{"Title":"AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain","Date":1600473600000}
{"Title":"AstraZeneca says COVID-19 vaccine trial in U.S. still on hold","Date":1600560000000}
{"Title":"AstraZeneca-Merck's Lynparza wins EU panel recommendation for cancer treatments","Date":1600646400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept 21","Date":1600646400000}
{"Title":"COVID-19 vaccine verdicts loom as next big market risk","Date":1600732800000}
{"Title":"COVID-19 vaccine makers see EU shield against side-effect claims","Date":1600732800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept. 24","Date":1600905600000}
{"Title":"AstraZeneca still waiting for FDA go-ahead to resume U.S. trial","Date":1600905600000}
{"Title":"Canada has signed deal for AstraZeneca vaccine candidate - PM","Date":1600992000000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Sept. 25","Date":1600992000000}
{"Title":"Exclusive: AstraZeneca gets partial immunity in low-cost EU vaccine deal","Date":1600992000000}
{"Title":"FTSE 100 pares early gains, set for second straight weekly loss","Date":1600992000000}
{"Title":"Exclusive: World Bank seeks board approval for $12 billion coronavirus vaccine financing plan","Date":1601337600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 1","Date":1601510400000}
{"Title":"Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sources","Date":1601510400000}
{"Title":"EU regulator launches real-time review of AstraZeneca's COVID-19 vaccine","Date":1601510400000}
{"Title":"AstraZeneca's Japanese COVID-19 vaccine trial back up, U.S. still paused","Date":1601596800000}
{"Title":"Nvidia building UK supercomputer to boost COVID-19 research","Date":1601856000000}
{"Title":"PM Johnson plays down technical failure of COVID-19 testing data system","Date":1601856000000}
{"Title":"EU reviewing Pfizer-BioNTech COVID-19 vaccine in real time","Date":1601942400000}
{"Title":"AstraZeneca could profit from COVID-19 vaccine as early as July - FT","Date":1602028800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct 8","Date":1602115200000}
{"Title":"U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump","Date":1602288000000}
{"Title":"As globe gallops into vaccine trials, insurers remain unfazed","Date":1602460800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 12","Date":1602460800000}
{"Title":"Worried European nations revive curfews, lockdowns amid 'exponential growth' in virus","Date":1602633600000}
{"Title":"Interested in the Novacyt share price? Read this first!","Date":1602633600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.62%","Date":1602633600000}
{"Title":"Britain moves closer to COVID-19 vaccine trials that infect volunteers","Date":1602806400000}
{"Title":"London stocks track Asia gains ahead of Brexit talks","Date":1603065600000}
{"Title":"Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources","Date":1603238400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct 21","Date":1603238400000}
{"Title":"Britain partners with Oxford firm to assess coronavirus vaccine T cell responses","Date":1603324800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 22","Date":1603324800000}
{"Title":"British midcaps jump on vaccine hopes, fresh stimulus","Date":1603324800000}
{"Title":"Fact Check: Trump and Biden\u2019s Second and Final Presidential Debate","Date":1603411200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 23","Date":1603411200000}
{"Title":"Dow Snaps 3-Week Win Streak as Stimulus Jitters Stifle Bulls","Date":1603411200000}
{"Title":"AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs","Date":1603411200000}
{"Title":"AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same","Date":1603497600000}
{"Title":"Europe prepares for more pain ahead as COVID surges","Date":1603670400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.98%","Date":1603670400000}
{"Title":"UK Stocks-Factors to watch on Oct 26","Date":1603670400000}
{"Title":"Banks help FTSE 100 pare losses due to weak commodity prices","Date":1603670400000}
{"Title":"Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - Times","Date":1603843200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 29","Date":1603929600000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Oct. 30","Date":1604016000000}
{"Title":"AstraZeneca sells commercial rights to two drugs in $400 million deal","Date":1604016000000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Nov 2","Date":1604275200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.39%","Date":1604448000000}
{"Title":"Healthcare, Gold Miners, Fed Statement: 3 Things to Watch","Date":1604448000000}
{"Title":"Britain prepares for COVID-19 vaccine as Oxford forecasts result this year","Date":1604448000000}
{"Title":"UK Stocks-Factors to watch on Nov 5","Date":1604534400000}
{"Title":"COVID vaccine deliveries on ice as AstraZeneca awaits trial data","Date":1604534400000}
{"Title":"UK Stocks-Factors to watch on Nov 6","Date":1604620800000}
{"Title":"Argentina agrees deal for 22 million doses of AstraZeneca-Oxford COVID-19 vaccine","Date":1604707200000}
{"Title":"Investors bet vaccine sparks revival in beaten down stocks","Date":1604880000000}
{"Title":"'Great day for humanity': Pfizer says COVID-19 vaccine over 90% effective","Date":1604880000000}
{"Title":"UK Stocks-Factors to watch on Nov 10","Date":1604966400000}
{"Title":"Oxford ups COVID-19 testing capacity with Thermo Fisher deal","Date":1604966400000}
{"Title":"Exclusive: Europe to pay less than U.S. for Pfizer vaccine under initial deal - source","Date":1605052800000}
{"Title":"COVID-19 'war games': the computer program that could help save your job","Date":1605052800000}
{"Title":"Why I volunteered for a COVID-19 vaccine trial","Date":1605139200000}
{"Title":"India's Serum says produced 40 million doses of AstraZeneca COVID-19 vaccine","Date":1605139200000}
{"Title":"CureVac deal takes EU's COVID vaccine supplies close to two billion","Date":1605484800000}
{"Title":"Pfizer shares drop as Moderna vaccine seen easier to distribute","Date":1605484800000}
{"Title":"Pfizer-BioNTech vaccine deliveries could start 'before Christmas'","Date":1605657600000}
{"Title":"'Where there's a will there's a way' as English doctors prepare COVID vaccine roll-out","Date":1605744000000}
{"Title":"Oxford's COVID-19 vaccine trial results 'definitely' before Christmas - investigator","Date":1605744000000}
{"Title":"AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas","Date":1605744000000}
{"Title":"Dow Slips on Concerns Over Recovery With Weaker Jobs, Restrictions","Date":1605744000000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.13%","Date":1606089600000}
{"Title":"UK Stocks-Factors to watch on Nov 24","Date":1606176000000}
{"Title":"Europe Confidence Slips, Bitcoin Corrects, Slack Talk - What's up in Markets","Date":1606348800000}
{"Title":"Point\/Counterpoint: The Case for AstraZeneca","Date":1606435200000}
{"Title":"Black Friday Arrives, Spanish Banks Turn Down Merger - What's up in Markets","Date":1606435200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Nov 27","Date":1606435200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Nov. 30","Date":1606694400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Dec 1","Date":1606780800000}
{"Title":"UK Stocks-Factors to watch on Dec 3","Date":1606953600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.36%","Date":1606953600000}
{"Title":"StockBeat: Just When You Thought It Was Safe to Get Back in the Water","Date":1607472000000}
{"Title":"UK Stocks-Factors to watch on Dec. 10","Date":1607558400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.68%","Date":1607904000000}
{"Title":"UK Stocks-Factors to watch on Dec 21","Date":1608508800000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Dec 21","Date":1608508800000}
{"Title":"UK Stocks-Factors to watch on Dec 22","Date":1608595200000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Dec 22","Date":1608595200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.50%","Date":1608681600000}
{"Title":"Wall St gains, dollar declines as extraordinary year winds down","Date":1609286400000}
{"Title":"McConnell Defies Trump, U.K. OKs Astra Vaccine, Bitcoin ATH - What's up in Markets","Date":1609286400000}
{"Title":"UK Stocks-Factors to watch on Dec 31","Date":1609372800000}
{"Title":"UK Stocks-Factors to watch on Jan. 4","Date":1609718400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 1.15%","Date":1610323200000}
{"Title":"English health official says have been extracting extra doses of AstraZeneca vaccine","Date":1610496000000}
{"Title":"Pounds hits near three-year high against the Dollar","Date":1611187200000}
{"Title":"UK plant producing AstraZeneca vaccines partially evacuated over suspect package","Date":1611705600000}
{"Title":"European Medicines Agency recommends EU Approval for AstraZeneca vaccine","Date":1611878400000}
{"Title":"EU's Von Der Leyen says Astrazeneca will deliver 9 million more vaccine doses","Date":1612051200000}
{"Title":"AstraZeneca to sell its holding in Viela Bio","Date":1612137600000}
{"Title":"European Stocks Higher; Corporate Earnings, Italian Politics Help","Date":1612310400000}
{"Title":"FTSE 100 broadly flat amid decline in services sector activity, BoE in focus","Date":1612310400000}
{"Title":"Global health officials back AstraZeneca vaccine after South Africa study rings alarm","Date":1612742400000}
{"Title":"FTSE 100 maintains march higher as miners rally","Date":1612742400000}
{"Title":"UK Stocks-Factors to watch on Feb. 8","Date":1612742400000}
{"Title":"UPDATE 1-UK Stocks-Factors to watch on Feb. 8","Date":1612742400000}
{"Title":"FTSE 100 slightly lower, Bitcoin the asset in focus","Date":1612828800000}
{"Title":"The UK stocks benefiting from vaccine-related news according to HSBC","Date":1612915200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 2.65%","Date":1613347200000}
{"Title":"Pound rally continues as cable breaks back above 1.3900","Date":1613606400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.38%","Date":1613692800000}
{"Title":"Astrazeneca denies vaccine delivery shortfall to EU, Italy - paper","Date":1614211200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.31%","Date":1615420800000}
{"Title":"FTSE 100 finishes lower as miners weigh, Bitcoin retreats from all-time high","Date":1615766400000}
{"Title":"AstraZeneca shares rise to the top of the FTSE despite vaccine concerns","Date":1615852800000}
{"Title":"Crude Oil Lower Amid Recovery Concerns; API Data in Focus","Date":1615852800000}
{"Title":"FTSE 100 closes higher, midcaps outperform, AstraZeneca jumps, oil lower","Date":1615852800000}
{"Title":"Rolls-Royce recent strength continues after JPMorgan upgrade","Date":1615939200000}
{"Title":"WATCH LIVE: European Medicines Agency Press Conference on AstraZeneca jab","Date":1616025600000}
{"Title":"GameStop, New Home Sales, AstraZeneca: 3 Things to Watch","Date":1616371200000}
{"Title":"Covid-19 Surge; Turkey Turmoil, GameStop Earnings - What's up in Markets","Date":1616371200000}
{"Title":"Powell, Yellen Testify; AstraZeneca\u2019s Vaccine, Housing Data - What's up in Markets","Date":1616457600000}
{"Title":"EU Will Tighten Restrictions on Covid Vaccine Export","Date":1616544000000}
{"Title":"European Stocks Mixed; EU Leaders Set to Discuss Covid","Date":1616630400000}
{"Title":"Suez Jam, Jobless Claims, AstraZeneca Update - What's up in Markets","Date":1616630400000}
{"Title":"FTSE 100 closes higher, GBP strong, Suez Canal remains blocked","Date":1616716800000}
{"Title":"Watch Live: European Medicines Agency press conference on AstraZeneca jab","Date":1617753600000}
{"Title":"Britain's medicine regulator will recommend halting rollout of AstraZeneca shots to under-30s, The Sun and Sky say","Date":1617753600000}
{"Title":"FTSE jumps amid weak GBP, possible link found between AZ jab and rare blood clots","Date":1617753600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.89%","Date":1617753600000}
{"Title":"Jobless Claims, Powell, AstraZeneca Vaccine - What's Moving Markets","Date":1617840000000}
{"Title":"Banks chime in on AstraZeneca amid vaccine news","Date":1617840000000}
{"Title":"U.S. Futures Edge Lower on J&J Shock; Crucial Inflation Data Looms","Date":1618272000000}
{"Title":"In world first, Denmark ditches AstraZeneca's COVID-19 shot","Date":1618358400000}
{"Title":"EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper","Date":1618358400000}
{"Title":"Bank Earnings, Coinbase Goes Public, IEA Hikes Oil Forecast - What's up in Markets","Date":1618358400000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 2.04%","Date":1618876800000}
{"Title":"Pharma names lift FTSE, Barclays declines, USD jumps on hawkish Kaplan","Date":1619740800000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.13%","Date":1619740800000}
{"Title":"Vaccine IP Waivers: Stealing from the Rich to Give to the Poor?","Date":1620777600000}
{"Title":"Walmart Profits, Home Depot Sales, Macy's Outlook: 3 Things to Watch","Date":1621209600000}
{"Title":"Denmark to reconsider exclusion of J&J and AstraZeneca shots","Date":1622419200000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.22%","Date":1623196800000}
{"Title":"Pfizer cuts Norway's COVID-19 vaccine deliveries, rollout delayed","Date":1623283200000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.87%","Date":1624838400000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.57%","Date":1625443200000}
{"Title":"Picky \"vaccine sommeliers\" undermine Brazil inoculation campaign, experts say","Date":1625788800000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 1.14%","Date":1626307200000}
{"Title":"AstraZeneca Earnings miss, Revenue beats In Q2","Date":1627516800000}
{"Title":"Fed Rattles Global Markets; Jobless Claims; Auto Chip Woe - What's Moving Market","Date":1629331200000}
{"Title":"British study shows COVID-19 vaccine efficacy wanes under Delta","Date":1629331200000}
{"Title":"UK market update \u2013 EasyJet rejects takeover offer, 888 buys William Hill assets","Date":1631145600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.84%","Date":1632096000000}
{"Title":"UK market update \u2013 Moonpig boosts guidance, Blue Prism agrees takeover","Date":1632787200000}
{"Title":"UK market update \u2013 Next raises guidance, Unilever shortlists bidders for tea unit","Date":1632873600000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.17%","Date":1632873600000}
{"Title":"UK market update \u2013 CDR wins bid for Morrisons, Plus500 boosts forecast","Date":1633305600000}
{"Title":"UK market update \u2013 Greggs raises forecast, Melrose warns on supply constraints","Date":1633392000000}
{"Title":"UK stocks drop over 1% as inflation worries weigh; Tesco jumps","Date":1633478400000}
{"Title":"UK update \u2013 Rio Tinto cuts iron ore shipment forecast, Pearson revenue up 10%","Date":1634256000000}
{"Title":"UK market update \u2013 HSBC initiates share buyback, Tesco suffers attempted hack","Date":1635120000000}
{"Title":"AstraZeneca to transfer some drug rights to Covis Pharma in $270 million deal","Date":1635724800000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.25%","Date":1635811200000}
{"Title":"AstraZeneca to set up division for vaccines and antibody therapies","Date":1636416000000}
{"Title":"European Stock Futures Edge Lower; U.S. Inflation, Earnings in Focus","Date":1636416000000}
{"Title":"AstraZeneca Earnings, Job Openings, Sentiment: 3 Things to Watch","Date":1636588800000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.51%","Date":1636675200000}
{"Title":"AstraZeneca, commodity stocks drag down UK's FTSE 100","Date":1636675200000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, LandSec, Avon Protection, Redrow, AVEVA","Date":1636675200000}
{"Title":"AstraZeneca Earnings miss, Revenue beats In Q3","Date":1636675200000}
{"Title":"AstraZeneca starts to make modest profit from COVID-19 vaccine","Date":1636675200000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.34%","Date":1637020800000}
{"Title":"AstraZeneca drags FTSE 100 lower, Vodafone surges on outlook","Date":1637020800000}
{"Title":"AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses","Date":1637020800000}
{"Title":"AstraZeneca's antibody cocktail helps prevent COVID-19 for at least 6 months","Date":1637193600000}
{"Title":"Britain's Prince Charles opens new AstraZeneca research centre","Date":1637625600000}
{"Title":"AstraZeneca examining impact of new COVID variant on vaccine, antibody cocktail","Date":1637884800000}
{"Title":"UK pre-market stocks update \u2013 Omicron, BT, AstraZeneca, AJ Bell, Hammerson, Amigo","Date":1638144000000}
{"Title":"UK pre-market stocks update \u2013 Glencore, easyJet, AstraZeneca, Wetherspoon","Date":1638230400000}
{"Title":"UK study finds mRNA COVID-19 vaccines provide biggest booster impact","Date":1638489600000}
{"Title":"UK pre-market stocks update \u2013 BT, AstraZeneca, Darktrace, WPP, Taylor Wimpey","Date":1638748800000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.48%","Date":1638835200000}
{"Title":"UK pre-market stocks update \u2013 GSK, BATS, AstraZeneca, SSE, Babcock","Date":1638835200000}
{"Title":"Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study","Date":1638835200000}
{"Title":"Demand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI","Date":1639008000000}
{"Title":"AstraZeneca to supply COVID-19 antibody cocktail to Singapore","Date":1639094400000}
{"Title":"Samsung Biologics, AstraZeneca expand tie-up to include COVID-19 and cancer therapy","Date":1639440000000}
{"Title":"India's billionaire Poonawalla family pledges $66 million to Oxford University","Date":1639526400000}
{"Title":"Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations","Date":1639526400000}
{"Title":"Refugees lack COVID shots because drugmakers fear lawsuits - documents","Date":1639612800000}
{"Title":"AstraZeneca therapy works against Omicron; results mixed for Regeneron","Date":1639612800000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, GSK, Rolls-Royce, Rio Tinto","Date":1639958400000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, Schroders, GSK, BHP, Foxtons","Date":1640044800000}
{"Title":"AstraZeneca, Oxford aim to produce Omicron-targeted vaccine","Date":1640044800000}
{"Title":"AstraZeneca vaccine booster works against Omicron, Oxford lab study finds","Date":1640217600000}
{"Title":"UK pre-market stocks update \u2013 Flutter, BHP, Balfour Beatty, Deliveroo","Date":1640217600000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, Anglo American, Fresnillo","Date":1640736000000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, Playtech, Ocado, Covid Update","Date":1641340800000}
{"Title":"UK pre-market stocks update \u2013 Shell, AstraZeneca, Aston Martin, C&C","Date":1641513600000}
{"Title":"New data finds AstraZeneca booster generates higher antibodies against Omicron","Date":1642032000000}
{"Title":"UK pre-market stocks update \u2013 Unilever, GSK, Taylor Wimpey, AstraZeneca","Date":1642377600000}
{"Title":"Asian Stocks Down, Bets on Fed Interest Rate Hikes Continue Upward Trend","Date":1644192000000}
{"Title":"UK pre-market stocks update \u2013 AstraZeneca, Unilever, Rolls-Royce, Redrow","Date":1644451200000}
{"Title":"AstraZeneca says COVID vaccine demand high in Latam, Middle East, Asia","Date":1644451200000}
{"Title":"AstraZeneca Earnings, Revenue beat in Q4","Date":1644451200000}
{"Title":"AstraZeneca sees higher 2022 sales even as COVID boost wanes","Date":1644451200000}
{"Title":"UK pre-market stocks update \u2013 British American Tobacco, AstraZeneca, Deliveroo","Date":1644537600000}
{"Title":"UK stocks rise on easing geopolitical tensions, AstraZeneca trial data","Date":1644883200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.01%","Date":1644883200000}
{"Title":"Exclusive-Short AstraZeneca shelf life complicates COVID vaccine rollout to world's poorest","Date":1644969600000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.43%","Date":1645401600000}
{"Title":"AstraZeneca's Stock Gain After Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting","Date":1645488000000}
{"Title":"Very small blood clot risk after first AstraZeneca COVID shot - UK studies","Date":1645488000000}
{"Title":"AstraZeneca chair Johansson to retire in 2023 after 11 years in role","Date":1645488000000}
{"Title":"AstraZeneca signs deal with Canada for 100,000 doses of COVID drug","Date":1645574400000}
{"Title":"AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants","Date":1645747200000}
{"Title":"AstraZeneca, Swiss firm Neurimmune ink $760 million deal for antibody drug","Date":1646092800000}
{"Title":"Britain approves AstraZeneca's preventative COVID therapy","Date":1647475200000}
{"Title":"AstraZeneca COVID drug neutralizes Omicron sub-variants in study","Date":1647820800000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.38%","Date":1649289600000}
{"Title":"Jim Cramer Gives His Opinion On AstraZeneca, Intuitive Surgical And More","Date":1650499200000}
{"Title":"The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid","Date":1651190400000}
{"Title":"AstraZeneca Earnings, Revenue beat in Q1","Date":1651190400000}
{"Title":"AstraZeneca says its COVID shot still has role despite global glut","Date":1651190400000}
{"Title":"AstraZeneca Tops Q1 EPS by $1.06","Date":1651190400000}
{"Title":"AstraZeneca ADR Earnings, Revenue beat in Q1","Date":1651190400000}
{"Title":"AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook","Date":1651190400000}
{"Title":"Inflation and GDP in the Eurozone: 5 Key Factors this Friday on the Stock Market","Date":1651190400000}
{"Title":"Former AstraZeneca oncology head to help All Blue in Zymeworks takeover bid","Date":1651536000000}
{"Title":"The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine","Date":1652227200000}
{"Title":"U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 1.45%","Date":1652227200000}
{"Title":"AstraZeneca boosts COVID portfolio with RQ Bio deal","Date":1652745600000}
{"Title":"EU health regulator backs using AstraZeneca COVID shot as booster","Date":1652918400000}
{"Title":"AstraZeneca says EU regulator approves COVID shot as booster","Date":1653264000000}
{"Title":"Innoviva Acquires AstraZeneca-Spin Off At $2.20\/Share","Date":1653264000000}
{"Title":"Cancer treatments may benefit from lessons of pandemic set-backs -AstraZeneca executive","Date":1653609600000}
{"Title":"New data sets stage for broader use of AstraZeneca breast cancer drug","Date":1654387200000}
{"Title":"AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%","Date":1654473600000}
{"Title":"The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial","Date":1655769600000}
{"Title":"Short Volatility Alert: AstraZeneca PLC","Date":1655856000000}
{"Title":"AstraZeneca gets EU backing for targeted breast cancer therapies","Date":1656288000000}
{"Title":"U.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.19%","Date":1656460800000}
{"Title":"AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial","Date":1656547200000}
{"Title":"Stellantis, Tesla, AstraZeneca Fall Premarket; Exxon Mobil Rises","Date":1656979200000}
{"Title":"AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion","Date":1656979200000}
{"Title":"AstraZeneca Unveils $1.27B Purchase of U.S. Biotech Firm TeneoTwo","Date":1656979200000}
{"Title":"European Stocks Drop; Economic Activity Concerns Weigh","Date":1656979200000}
{"Title":"Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer Study","Date":1658188800000}
{"Title":"Oil Producers, Procter & Gamble, AstraZeneca: 3 Things to Watch","Date":1658966400000}
{"Title":"AstraZeneca Earnings, Revenue beat in Q2","Date":1659052800000}
{"Title":"AstraZeneca follows the trend in the sector to upgrade guidance as Covid vaccines sales show resilience","Date":1659052800000}
{"Title":"AstraZeneca ADR Earnings, Revenue beat in Q2","Date":1659052800000}
{"Title":"AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance","Date":1659052800000}
{"Title":"AstraZeneca lifts revenue guidance on COVID treatment","Date":1659052800000}
{"Title":"AstraZeneca CEO Soriot says to work with new chairman for many years","Date":1659052800000}
{"Title":"AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer","Date":1659312000000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1659312000000}
{"Title":"Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial","Date":1659312000000}
{"Title":"AstraZeneca says Lynparza gets EU nod to treat early-stage breast cancer","Date":1659571200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1659571200000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1659571200000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1659657600000}
{"Title":"FTSE 100 positive but off early highs","Date":1660521600000}
{"Title":"European Stocks Edge Higher; Weak Chinese Data Hits Sentiment","Date":1660521600000}
{"Title":"FTSE 100 up as AstraZeneca gains offset commodity losses","Date":1660521600000}
{"Title":"Sanofi Shares Slide After Trials of Potential Breast Cancer Drug Halted","Date":1660694400000}
{"Title":"Exclusive: AstraZeneca may not stay in vaccines, but CEO has no COVID regrets","Date":1661212800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1661212800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1662508800000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1662508800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1662681600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1663113600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1663200000000}
{"Title":"Market movers: Property groups fall as Goldman\/JPMorgan reduce price targets","Date":1663286400000}
{"Title":"EU backs AstraZeneca's drug for prevention of infant RSV","Date":1663286400000}
{"Title":"EU regulator backs wider use of AstraZeneca COVID therapy","Date":1663286400000}
{"Title":"AstraZeneca says Evusheld\u00a0approved for treatment of COVID-19 in EU","Date":1663632000000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1663632000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1663718400000}
{"Title":"AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med","Date":1663891200000}
{"Title":"AstraZeneca gets its third regulatory green light in a matter of weeks for asthma drug","Date":1664236800000}
{"Title":"AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know","Date":1664668800000}
{"Title":"AstraZeneca pays 660% premium for gene therapy firm LogicBio","Date":1664755200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1666051200000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1666137600000}
{"Title":"AstraZeneca says Imjudo-Imfinzi combination approved for advanced liver cancer in US","Date":1666569600000}
{"Title":"AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings","Date":1666742400000}
{"Title":"AstraZeneca shares will get lift from heartburn drug litigation closure, says Citi","Date":1667260800000}
{"Title":"Astrazeneca's Beyfortus receives EU approval","Date":1667520000000}
{"Title":"FDA committee votes in favour of AstraZeneca asthma candidate","Date":1667952000000}
{"Title":"AstraZeneca ADR Earnings, Revenue beat in Q3","Date":1668038400000}
{"Title":"Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11","Date":1668038400000}
{"Title":"AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength","Date":1668038400000}
{"Title":"AstraZeneca raises 2022 earnings outlook after Q3 results beat estimates","Date":1668038400000}
{"Title":"Nasdaq, S&P 500 Futures Show Cautious Optimism Ahead Of October Inflation Print \u2014 Tesla, Rivian, Apple, AstraZeneca In Focus","Date":1668038400000}
{"Title":"AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results","Date":1668038400000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1668470400000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1668556800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1668729600000}
{"Title":"UK's C4X Discovery signs $400 million licensing deal with AstraZeneca","Date":1669593600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1669680000000}
{"Title":"AstraZeneca acquires biotech Neogene for $320M in bid to expand cancer treatments","Date":1669680000000}
{"Title":"AstraZeneca boosts cancer portfolio with $320 million Neogene deal","Date":1669680000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1670544000000}
{"Title":"Amgen secures $28.3 billion deal to buy Horizon Therapeutics","Date":1670803200000}
{"Title":"AstraZeneca attractive in near term but patent cliffs loom, says broker","Date":1670976000000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1671062400000}
{"Title":"AstraZeneca's Forxiga recommended for EU approval, James Fisher sells three businesses","Date":1671408000000}
{"Title":"AstraZeneca slips after Imfinzi falls short in cancer trial","Date":1671408000000}
{"Title":"AstraZeneca gets new approvals in Japan on three drugs","Date":1672185600000}
{"Title":"Exclusive-Drugmakers to raise prices on at least 350 drugs in U.S. in January","Date":1672358400000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1672704000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1672790400000}
{"Title":"AstraZeneca: Has the market factored in the full value of potential cancer blockbuster?","Date":1672876800000}
{"Title":"GSK, AstraZeneca: Will the two UK drugs giants ride the US$74bn pharma wave or will they be left beached?","Date":1672963200000}
{"Title":"AstraZeneca to buy US-based CinCor in $1.8bn deal","Date":1673222400000}
{"Title":"European stocks edge higher; German industrial production impresses","Date":1673222400000}
{"Title":"AstraZeneca to buy U.S. biotech CinCor for as much as $1.8 billion","Date":1673222400000}
{"Title":"London midday: Stocks nudge lower despite China hopes","Date":1673222400000}
{"Title":"AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal","Date":1673222400000}
{"Title":"AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline","Date":1673222400000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1674000000000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1674604800000}
{"Title":"Top 5 Health Care Stocks That May Rally","Date":1675382400000}
{"Title":"PepsiCo, AstraZeneca, PayPal earnings: 3 things to watch","Date":1675814400000}
{"Title":"AstraZeneca: Will pharma giant beat revenue expectations?","Date":1675814400000}
{"Title":"European stocks higher; German consumer price increases slow","Date":1675900800000}
{"Title":"AstraZeneca Q4 core earnings beat estimates despite easing COVID vaccine demand","Date":1675900800000}
{"Title":"AstraZeneca CEO says UK business climate deters investment","Date":1675900800000}
{"Title":"FTSE 100 holds near new record high; US stocks seen up as weekly jobless claims rise","Date":1675900800000}
{"Title":"AstraZeneca goes for growth with new drugs as COVID sales wane","Date":1675900800000}
{"Title":"European stock futures higher; German CPI, Credit Suisse in focus","Date":1675900800000}
{"Title":"AstraZeneca pipeline worth the current premium, says broker","Date":1676332800000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1676419200000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1676937600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1676937600000}
{"Title":"AstraZeneca signs deal to produce new gastric cancer drug","Date":1677110400000}
{"Title":"AstraZeneca's Imfinzi trial shows 'significantly improved' event-free survival rates","Date":1678320000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1678752000000}
{"Title":"How GSK plans to replenish its depleted medicine cabinet","Date":1678838400000}
{"Title":"AstraZeneca PT receives Investment Bank Analyst Rating Update","Date":1678838400000}
{"Title":"AstraZeneca reports positive analysis from ovarian cancer trial","Date":1680652800000}
{"Title":"UK court orders GSK to pay AstraZeneca royalties on total sales of Zejula","Date":1680652800000}
{"Title":"UK's FTSE 100 climbs on upbeat services sector data; AstraZeneca jumps","Date":1680652800000}
{"Title":"AstraZeneca releases US$0.7bn after simplifying US RSV deal","Date":1681171200000}
{"Title":"FTSE 100 opens sharply higher, mining and oil stocks provide support","Date":1681171200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1681171200000}
{"Title":"FTSE 100 in positive mood, IMF sees rates falling to pre-Covid levels","Date":1681171200000}
{"Title":"FTSE 100 maintains gains as US stocks seen mixed; bitcoin back above $30k","Date":1681171200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1681776000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1681776000000}
{"Title":"AstraZeneca results arrive with focus on drug trials, while GSK still faces Zantac overhang","Date":1682035200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1682035200000}
{"Title":"FTSE 100 opens lower, AstraZeneca overtakes US rival Pfizer","Date":1682294400000}
{"Title":"FTSE 100 dragged lower by mining and oil, Sunak to meet UK business heads","Date":1682294400000}
{"Title":"AstraZeneca in uncharted waters as shares rocket higher","Date":1682380800000}
{"Title":"GSK minds the gap as AstraZeneca streaks ahead","Date":1682380800000}
{"Title":"FTSE 100 movers: Miners, banks decline; Whitbread rallies","Date":1682380800000}
{"Title":"FTSE 100 pares losses as housebuilders lifted by Persimmon green shoots","Date":1682467200000}
{"Title":"London close: Stocks lower amid another batch of earnings","Date":1682467200000}
{"Title":"Europe midday: Shares muted ahead of flash US GDP data","Date":1682553600000}
{"Title":"FTSE 100 holds around opening levels, Barclays rises after strong results","Date":1682553600000}
{"Title":"Europe open: Shares flat amid earnings deluge; SimCorp surges on bid","Date":1682553600000}
{"Title":"London open: Stocks steady amid corporate deluge","Date":1682553600000}
{"Title":"AstraZeneca beats estimates on strong emerging market sales as COVID wanes","Date":1682553600000}
{"Title":"FTSE 100 resilient, Barclays and Unilever rise on upbeat trading","Date":1682553600000}
{"Title":"FTSE 100 seen lower, Barclays beats expectations, Unilever sales jump","Date":1682553600000}
{"Title":"FTSE 100 seen lower, Barclays profit beats expectations","Date":1682553600000}
{"Title":"European stocks mixed; results from Barclays, Deutsche Bank in focus","Date":1682553600000}
{"Title":"FTSE 100 seen lower on banking concerns; Meta flies high","Date":1682553600000}
{"Title":"Drugmakers scout for deals, ramp up research spending","Date":1682640000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1682640000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1682812800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1682812800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1683590400000}
{"Title":"AstraZeneca reports positive results in latest lung cancer trials","Date":1684281600000}
{"Title":"AstraZeneca hails the findings from cancer combination trial","Date":1685059200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1685404800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1685404800000}
{"Title":"AstraZeneca gets another US approval for Lynparza","Date":1685577600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1686009600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1686009600000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1686096000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1686096000000}
{"Title":"AstraZeneca places US$85mln bet on autoimmune cell therapy with\u00a0Quell deal","Date":1686268800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1687305600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1687305600000}
{"Title":"Novo Nordisk says EMA raised safety signal on drugs including semaglutide","Date":1687392000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1687824000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1687824000000}
{"Title":"AstraZeneca shares dip after lung cancer drug trial update 'disappoints' hopes","Date":1688342400000}
{"Title":"Asian stocks struggle amid economic jitters, Nikkei slides","Date":1688428800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1688428800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1688515200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1689120000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1689206400000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1689292800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1689292800000}
{"Title":"AstraZeneca number show how it is 'not a one-trick pony' - analyst","Date":1690502400000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1691366400000}
{"Title":"European shares sink to lowest in six weeks, China woes loom large","Date":1692316800000}
{"Title":"AstraZeneca facing two London lawsuits over COVID-19 vaccines","Date":1692748800000}
{"Title":"More AstraZeneca drugs to be added to US IRA list, Barclays predicts","Date":1693440000000}
{"Title":"AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts","Date":1694390400000}
{"Title":"AstraZeneca seeks to calm CEO speculation after shares drop","Date":1694390400000}
{"Title":"AstraZeneca bounces back from reports that CEO Soriot is eyeing exit","Date":1694476800000}
{"Title":"GSK opens new site in UK, unlike rival AstraZeneca","Date":1694649600000}
{"Title":"EU regulator backs AstraZeneca and Daiichi's lung cancer drug (Sept. 15)","Date":1694995200000}
{"Title":"London midday: Markets \"calm\" ahead of Fed and BoE meetings","Date":1695081600000}
{"Title":"AstraZeneca signals strong results from breast cancer drug trial","Date":1695340800000}
{"Title":"JPMorgan advocates for energy stocks, anticipates supply-demand gap post-2025","Date":1695340800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1695427200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1695427200000}
{"Title":"AstraZeneca growth opportunities 'overlooked' - Jefferies","Date":1695600000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1695600000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1695600000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1696032000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1696032000000}
{"Title":"London midday: Stocks extend gains after UK GDP, ahead of US CPI","Date":1697068800000}
{"Title":"London midday: Stocks gain on commodities boost","Date":1697414400000}
{"Title":"AstraZeneca leads FTSE fallers for no obvious reason","Date":1697587200000}
{"Title":"AstraZeneca shares fall as lung cancer drug trial data abstract disappoints","Date":1697587200000}
{"Title":"AstraZeneca gains European approval for lung cancer drug","Date":1698019200000}
{"Title":"LumiraDx surges after partnering with AstraZeneca, Everton on England's first heart and lung screening hub","Date":1698019200000}
{"Title":"FTSE 100 Dips as Fresnillo Leads Losses, Flutter Entertainment Tops Gainers","Date":1698019200000}
{"Title":"Barclays and AstraZeneca up staff pay as Real Living Wage increases","Date":1698105600000}
{"Title":"S&P 500 companies gear up for third-quarter reports amid economic indicators","Date":1699228800000}
{"Title":"AstraZeneca reports, Li Auto earnings, Tapestry: 3 things to watch","Date":1699401600000}
{"Title":"London open: FTSE little changed after China data, earnings avalanche","Date":1699488000000}
{"Title":"AstraZeneca's Imfinzi shows promise in liver cancer treatment","Date":1699488000000}
{"Title":"AstraZeneca raises annual profit forecast as China's CPI contracts","Date":1699488000000}
{"Title":"FTSE 250 is lagging the blue-chip FTSE 100 index in 2023","Date":1699574400000}
{"Title":"Investigating AstraZeneca's Standing In Pharmaceuticals Industry Compared To Competitors","Date":1699833600000}
{"Title":"AstraZeneca's Imfinzi misses primary endpoint in Phase III lung cancer trial","Date":1699920000000}
{"Title":"UK stocks rally on rate cut hopes and AstraZeneca's drug approval","Date":1700179200000}
{"Title":"AstraZeneca: Leading bank tells us why the stock is a core holding","Date":1700438400000}
{"Title":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise","Date":1701043200000}
{"Title":"FTSE 100 movers: Entain hit by downgrade; Rightmove rallies","Date":1701043200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1701129600000}
{"Title":"AstraZeneca halts Phase III trials for kidney disease treatment","Date":1701388800000}
{"Title":"Abbvie's $10bn swoop puts the spotlight on antibody-drug conjugates stocks","Date":1701388800000}
{"Title":"AstraZeneca discontinues phase III trials","Date":1701388800000}
{"Title":"AstraZeneca ends two Phase III trials due to enrollment issues","Date":1701648000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1701734400000}
{"Title":"AstraZeneca and the world according to GARP","Date":1701820800000}
{"Title":"AstraZeneca boosts RSV profile with US$1.1bn Icosavax deal","Date":1702339200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1702425600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1702425600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1702598400000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1702598400000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1702944000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1702944000000}
{"Title":"Lloyds, AstraZeneca, BATs, Rolls-Royce: What's on the menu for 2024?","Date":1702944000000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1703548800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1703548800000}
{"Title":"FTSE 100 Live: Stocks fade as birthday celebrations fall flat","Date":1704240000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1704240000000}
{"Title":"AstraZeneca: Leading bank bullish after key conference appearance","Date":1705276800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1705363200000}
{"Title":"London midday: Stocks stay up as sterling falls on weak retail sales","Date":1705622400000}
{"Title":"SOPHiA GENETICS expands ovarian cancer testing in Spain","Date":1707264000000}
{"Title":"AstraZeneca sees \u00a32.8bn knocked off its value amid cost concerns","Date":1707350400000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1707350400000}
{"Title":"FTSE 100 concede gains as AstraZeneca slides on earnings miss","Date":1707350400000}
{"Title":"Deutsche Bank cuts AstraZeneca to sell, lowers target to \u00a395","Date":1707350400000}
{"Title":"European shares edge lower as healthcare losses overpower earnings-fuelled rally","Date":1707350400000}
{"Title":"FDA grants Fast Track to Ionis and AstraZeneca's ATTR-CM treatment","Date":1707436800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1707436800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1707696000000}
{"Title":"FTSE 100 lower, TUI questions London listing after record quarter","Date":1707782400000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1707955200000}
{"Title":"AstraZeneca\u2019s new lung cancer drugs to boost sales - UBS","Date":1708300800000}
{"Title":"AstraZeneca\u2019s stock surges on FTSE 100 on Tagrisso approval","Date":1708300800000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1708387200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1708387200000}
{"Title":"Silence Therapeutics receives $10M from AstraZeneca trial","Date":1708646400000}
{"Title":"AstraZeneca to invest \u00a3650mln in UK life sciences","Date":1709683200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1710288000000}
{"Title":"FTSE 100 Live: Stocks in the green, AstraZeneca buys Fusion, Unilever splits ice cream","Date":1710806400000}
{"Title":"Puma Biotech's lawsuit against AstraZeneca progresses","Date":1710806400000}
{"Title":"Japan approves AstraZeneca's Truqap for breast cancer treatment","Date":1711497600000}
{"Title":"AstraZeneca's Beyfortus gets approval in Japan for RSV prevention","Date":1711497600000}
{"Title":"AstraZeneca's breast cancer treatment BLA gets FDA nod","Date":1712016000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1712275200000}
{"Title":"FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers","Date":1712361600000}
{"Title":"Lok\u2019nStore, AstraZeneca, Darktrace, Distil, European Metals, XPS Pensions, Mast Energy \u2013 Stocks on the move","Date":1712793600000}
{"Title":"FTSE 100 Live: Index nears record as miners, housebuilders rally; Gold surges","Date":1712880000000}
{"Title":"AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition","Date":1712880000000}
{"Title":"AstraZeneca upgrade (of sorts) by leading investment bank","Date":1713225600000}
{"Title":"Lloyds, Sainsbury's and AstraZeneca feature as big names report: Week ahead","Date":1713484800000}
{"Title":"EU approves AstraZeneca's new PNH treatment","Date":1713830400000}
{"Title":"Morning Bid: Gearing up for the tech roller-coaster ride","Date":1714003200000}
{"Title":"FTSE 100 Live: Index at record; Anglo American soars on BHP bid; Barclays, AstraZeneca up","Date":1714003200000}
{"Title":"AstraZeneca shares jump on much stronger Q1 top and bottom line","Date":1714003200000}
{"Title":"AstraZeneca overtakes Shell as Britain\u2019s most valuable company","Date":1714003200000}
{"Title":"FTSE 100 hits record high on BHP bid for Anglo American, earnings push","Date":1714003200000}
{"Title":"AstraZeneca shares worth \u00a3135, says investment bank","Date":1714089600000}
{"Title":"FTSE 100 Live: Stocks to smash new record, Anglo American rejects BHP bid, NatWest reports","Date":1714089600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1714262400000}
{"Title":"AstraZeneca tells court Covid vaccine can cause rare side effect","Date":1714348800000}
{"Title":"AstraZeneca to present respiratory disease research at ATS 2024","Date":1714521600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1715040000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1715126400000}
{"Title":"Microsoft, Amazon and AstraZeneca invest billions in France","Date":1715558400000}
{"Title":"AstraZeneca lays out plans for $1.5bn Singapore plant","Date":1716163200000}
{"Title":"AstraZeneca to invest $1.5 billion in Singapore ADC facility","Date":1716163200000}
{"Title":"Blue-chips fall out of bed, Pennon hits water companies, AstraZeneca rises","Date":1716249600000}
{"Title":"AstraZeneca's new 2030 targets are bold attempt to reach for the stars, say analysts","Date":1716249600000}
{"Title":"AstraZeneca: Leading banks hail Soriot's $80bn target; more detail sought","Date":1716336000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1716336000000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1716508800000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1716854400000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1717027200000}
{"Title":"AstraZeneca finalizes Fusion Pharmaceuticals buyout","Date":1717459200000}
{"Title":"AstraZeneca receives Investment Bank Analyst Rating Update","Date":1717459200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1717459200000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1717545600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1717977600000}
{"Title":"Farxiga gains FDA nod for pediatric type-2 diabetes","Date":1718150400000}
{"Title":"AstraZeneca disappointed with failure of immunotherapy in early-stage lung cancer","Date":1719273600000}
{"Title":"Astrazeneca receives Investment Bank Analyst Rating Update","Date":1719878400000}
